Skip to main content

and
  1. No Access

    Article

    An Investigation of Instability in Dried Blood Spot Samples for Pharmacokinetic Sampling in Phase 3 Trials of Verubecestat

    In-clinic dried blood spot (DBS) pharmacokinetic (PK) sampling was incorporated into two phase 3 studies of verubecestat for Alzheimer’s disease (EPOCH [NCT01739348] and APECS [NCT01953601]), as a potential al...

    Melanie Anderson, Marissa F. Dockendorf, Ian McIntosh, Iris **e in The AAPS Journal (2022)

  2. No Access

    Article

    A Model-Based Approach to Bridging Plasma and Dried Blood Spot Concentration Data for Phase 3 Verubecestat Trials

    In-clinic venous dried blood spot (DBS) pharmacokinetic (PK) sampling was incorporated into two phase 3 studies of verubecestat for Alzheimer’s disease (EPOCH [NCT01739348] and APECS [NCT01953601]), as a poten...

    Marissa F. Dockendorf, David Jaworowicz, Rebecca Humphrey in The AAPS Journal (2022)

  3. No Access

    Protocol

    Intact Mass Quantitation of Therapeutic Antibodies for Pharmacokinetic Studies Using Immuno-Purification

    The quantitation of therapeutic antibodies by mass spectrometry often utilizes a surrogate peptide approach following enzymatic digestion of the antibody. Although this approach has been widely adopted, it is ...

    Lisa A. Vasicek, Daniel S. Spellman, Kevin P. Bateman in Therapeutic Antibodies (2022)

  4. Article

    Open Access

    An Integrated Strategy for Implementation of Dried Blood Spots in Clinical Development Programs

    Dried blood spot (DBS) sample collection has gained increased interest across the pharmaceutical industry as a potential alternative to plasma for pharmacokinetic (PK) evaluations. However, regulatory guidelin...

    Prajakti A. Kothare, Kevin P. Bateman, Marissa Dockendorf, Julie Stone in The AAPS Journal (2016)

  5. Article

    Open Access

    Desaturation index versus isotopically measured de novo lipogenesis as an indicator of acute systemic lipogenesis

    High carbohydrate feeding is known to increase plasma triglycerides as well as hepatic de novo lipogenesis (DNL) and may be implicated in the development of hepatic insulin resistance and fatty liver. Unfortunate...

    Scott V Harding, Kevin P Bateman, Brian P Kennedy, Todd C Rideout in BMC Research Notes (2015)

  6. Article

    Quantitative-qualitative data acquisition using a benchtop orbitrap mass spectrometer

    Current approaches to discovery-stage drug metabolism studies (pharmacokinetics, microsomal stability, etc. ) typically use triple-quadrupole-based approaches for quantitative analysis. This necessitates the o...

    Kevin P. Bateman, Markus Kellmann in Journal of the American Society for Mass S… (2009)

  7. No Access

    Protocol

    Glycoprotein Analysis by Capillary Zone Electrophoresis-Electrospray Mass Spectrometry

    The study of glycoproteins as intact molecules or as smaller fragments generated by chemical or enzymatic digestion is well suited to the technique of capillary zone electrophoresis-electrospray mass spectrome...

    Kevin P. Bateman, John F. Kelly in Capillary Electrophoresis of Carbohydrates (2003)

  8. Article

    Development of generic liquid chromatography-mass spectrometry methods using experimental design

    Standard approaches to development of liquid chromatography-mass spectrometry (LC-MS) methods, either ion-pairing or reversed-phase liquid chromatography, have been through trial and error or intentional varia...

    Carmai Seto, Kevin P. Bateman, Berton Gunter in Journal of the American Society for Mass S… (2002)

  9. No Access

    Article

    Electrochemical properties of capillary electrophoresis-nanoelectrospray mass spectrometry

    Electrochemical properties are inherent to the techniques of electrophoresis and electrospray ionization. Interfacing capillary zone electrophoresis (CZE) with electrospray mass spectrometry (ESMS) can lead to...

    Kevin P. Bateman in Journal of the American Society for Mass Spectrometry (1999)